Glenn E Fritz

Title: Glenn E. Fritz: Innovator in Pharmaceutical Formulations

Introduction

Glenn E. Fritz is a notable inventor based in Arlington, TN (US). He has made significant contributions to the field of pharmaceuticals, particularly in the formulation of medications for improved absorption.

Latest Patents

Glenn E. Fritz holds a patent for "Phenylephrine pharmaceutical formulations and compositions for colonic absorption." This invention discloses a pharmaceutical composition that includes phenylephrine or a pharmaceutically acceptable salt thereof, designed for oral administration. The composition features an erodible layer that facilitates the delivery of phenylephrine via absorption in the colon. The core of the composition is encased in a time-dependent, pH-dependent, or colon-specific enzyme-dependent erodible layer, which degrades to release phenylephrine in the colon. Additionally, the composition may include other therapeutically active agents such as antihistamines, analgesics, anti-pyretics, and non-steroidal anti-inflammatory agents.

Career Highlights

Glenn E. Fritz is associated with MSD Consumer Care, Inc., where he continues to innovate in the pharmaceutical sector. His work focuses on enhancing the bioavailability of therapeutically active unconjugated phenylephrine in the plasma.

Collaborations

Some of his notable coworkers include David Monteith and John O'Mullane, who contribute to the collaborative efforts in research and development within the company.

Conclusion

Glenn E. Fritz is a distinguished inventor whose work in pharmaceutical formulations has the potential to improve therapeutic outcomes for patients. His innovative approach to drug delivery systems exemplifies the importance of research and development in the pharmaceutical industry.